• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (5)
    • Epigenetic therapy inhibits metastases by disrupting premetastatic niches.
    • Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol.
    • Growth factor requirement for survival in cell-cycle dormancy of primitive murine lymphohematopoietic progenitors.
    • IL6 Fuels Durable Memory for Th17 Cell-Mediated Responses to Tumors.
    • Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients.
    • See All 5 Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Epigenetic therapy inhibits metastases by disrupting premetastatic niches.

Epigenetic therapy inhibits metastases by disrupting premetastatic niches. Nature. 2020 03; 579(7798):284-290.

View in: PubMed

subject areas
  • Animals
  • Azacitidine
  • Benzamides
  • Cell Differentiation
  • Cell Movement
  • Chemotherapy, Adjuvant
  • Disease Models, Animal
  • Down-Regulation
  • Epigenesis, Genetic
  • Genetic Therapy
  • Mice
  • Myeloid-Derived Suppressor Cells
  • Neoplasm Metastasis
  • Neoplasms
  • Pyridines
  • Receptors, CCR2
  • Receptors, Interleukin-8B
  • Tumor Microenvironment

authors with profiles
  • John Mcelmurray Wrangle